ESR1 and breast cancer: High mRNA levels in breast cancer of the positive regulator TIMELESS has been significantly associated with shorter relapse-free survival and recently been regarded as a promising marker of tamoxifen resistance in women with estrogen receptor alpha-positive breast tumors[51].